Effectiveness and Safety of Low-Level Red Light and Short-Wavelength Light Therapy for Myopia Control and Prevention in Children: A Systematic Review
Wirksamkeit und Sicherheit von Low-Level Red Light- und Kurzwelllichttherapie zur Myopiekontrolle und -prävention bei Kindern: systematische Übersicht
Journal of Clinical Medicine · 01.11.2026 · 15 (21) · 8493
DOI: 10.3390/jcm15218493 ↗Auf einen Blick
Die Übersichtsarbeit zu Lichttherapien bei kindlicher Myopie fand für Low-Level Red Light eine Verlangsamung der Myopieprogression. Für die Langzeitsicherheit bleibt die Evidenz unzureichend.
Fragestellung
Wie wirksam und sicher sind Low-Level Red Light- und Kurzwelllichttherapie zur Myopiekontrolle bei Kindern?
Methode
Systematische Übersicht; Suche in PubMed, Web of Science, Scopus, Google Scholar und EBSCO nach Studien von 2013 bis 2026; Qualitätsbewertung mit der Downs and Black checklist.
Ergebnisse
26 Studien zu LLRL berichteten eine verlangsamte Myopieprogression, geringere AL-Zunahme und SER-Progression sowie höhere makuläre CT. 6 Studien zu Kurzwelllicht zeigten geringere AL-Zunahme und kurzfristige choroidale Veränderungen.
Einschränkungen
Berichtete retinale strukturelle und funktionelle Veränderungen sowie okuläre Oberflächensymptome; Langzeitsicherheit unzureichend geklärt.
Schlussfolgerung der Autor:innen
Lichtbasierte Therapien, besonders LLRL und Kurzwelllicht, erscheinen als nicht-pharmakologische Optionen zur Myopiekontrolle; die Langzeitsicherheit ist jedoch weiterhin unzureichend belegt.
Kernaussagen
- LLRL verlangsamte die Myopieprogression bei Kindern.
- Kurzwelllicht reduzierte die axiale Längen-Zunahme in 6 Studien.
- Langzeitsicherheit und retinale Veränderungen erfordern weitere Prüfung.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.11.2026. Verfasst von Saif Hassan Alrasheed und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Optometry, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Myopia is a major public health challenge, particularly among children, with prevalence increasing worldwide. Emerging light-based interventions, including low-level red light (LLRL) and short-wavelength light therapy, may be effective for myopia control. This systematic review aimed to assess the effectiveness and safety of LLRL and short-wavelength light therapy for myopia control in children.
Methods
A systematic search was performed in PubMed, Web of Science, Scopus, Google Scholar, and EBSCO in accordance with PRISMA 2020 guidelines. Studies published between 2013 and 2026 assessing the effectiveness and safety of LLRL and short-wavelength therapies for myopia control were included. The quality of the included studies was assessed using the Downs and Black checklist. Intervention outcomes included changes in axial length (AL), spherical equivalent refraction (SER), and choroidal thickness (CT). Safety outcomes comprised evaluations of both structural and functional retinal damage, along with assessment of ocular surface complications following the intervention. The review protocol was registered in PROSPERO (with registration number CRD420261289443).
Results
Twenty-six studies reported that LLRL therapy effectively slowed myopia progression in children; however, some retinal structural and functional changes warrant further long-term safety evaluation. LLRL significantly reduced AL elongation and SER progression, increased macular CT, and delayed the onset of myopia. Some studies indicated that LLRL therapy may achieve greater efficacy in myopia control compared with 0.01% atropine. Reported adverse events include photophobia, dry eye symptoms, altered color perception, conjunctivitis, and visual discomfort. Six studies showed that short-wavelength light therapy reduced AL elongation and induced short-term choroidal changes. No serious ocular or systemic adverse events were reported with short-wavelength light therapy; however, long-term safety requires further investigation.
Conclusions
Light-based therapies, particularly LLRL and short-wavelength light interventions, show promise as non-pharmacological approaches for myopia control; conversely, current evidence remains insufficient to establish their long-term safety. LLRL therapy has demonstrated efficacy in reducing AL, increasing CT, and delaying SER progression. However, reported retinal changes and ocular surface symptoms underscore the importance of close monitoring, standardized treatment protocols, and long-term safety evaluation in large-scale clinical trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Optometry, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.
ORCID-Profile: Saif Hassan Alrasheed, Naveen Kumar Challa
Zitieren
APA
Alrasheed, S. H., & Challa, N. K. (2026). Effectiveness and Safety of Low-Level Red Light and Short-Wavelength Light Therapy for Myopia Control and Prevention in Children: A Systematic Review. Journal of Clinical Medicine, 15(21), 8493. https://doi.org/10.3390/jcm15218493
Vancouver
Alrasheed SH, Challa NK. Effectiveness and Safety of Low-Level Red Light and Short-Wavelength Light Therapy for Myopia Control and Prevention in Children: A Systematic Review. Journal of Clinical Medicine. 2026;15(21):8493. doi:10.3390/jcm15218493
BibTeX
@article{Alrasheed2026,
author = {Alrasheed, Saif Hassan and Challa, Naveen Kumar},
title = {Effectiveness and Safety of Low-Level Red Light and Short-Wavelength Light Therapy for Myopia Control and Prevention in Children: A Systematic Review},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {21},
pages = {8493},
doi = {10.3390/jcm15218493}
}
EUVIMED